Press releases and articles
AI/ML-based drugmaker gets FDA green light for Phase I study
Veteran Biopharma Operations Leader Tina M. Larson to Join Recursion as Chief Operating Officer
Recursion Receives FDA Clearance of Investigational New Drug Application to Initiate First Clinical Trial of REC-994 in Cerebral Cavernous Malformation
Ron Alfa at AI in Healthcare, WPM18
Data Science Meetup: Lindsay (Anderson) Zuloaga
Blogs and Publications
This section provides resources and assets for media partners and journalists looking for background information about Recursion Pharmaceuticals. In this section, you will find corporate descriptions, biographies of our founders, approved images, and logos. There are many stories to tell about our innovative approach to drug discovery. We welcome you to use this information as a starting point in your story development and reach out to us for interviews and specific details related to your areas of interest.